AMA Guides Digital Cedaron
Home
AMA Guides Editions ▾
  • 6th Edition 2025
  • 6th Edition 2024
  • 6th Edition 2023
  • 6th Edition 2022
  • 6th Edition 2021
  • 6th Edition 2008
  • 5th Edition
  • 4th Edition
  • 3rd Edition Revised
AMA Guides Newsletters Search Case Scenarios Subscribe Log In

AMA Guides® Newsletter - Issue Archive

Volume 20 (2015): Issue 1 (Jan) < Previous Issue Next Issue >

Articles

  1. Peripheral Nerve Entrapment Impairments Revisited: Part I

    J. Mark Melhorn, James B. Talmage, Charles N. Brooks

    Pages 3–8

    DOI: 10.1001/amaguidesnewsletters.2015.JanFeb01

    Abstract
    The AMA Guides to the Evaluation of Permanent Impairment (AMA Guides), Sixth Edition, introduced the concept of diagnosis-based impairments (DBI), and a modified version of this method can be used in rating peripheral nerve injury in general (Section 5.4) and upper limb entrapment syndromes (Section 15.4f). The first portion of this article reviews the evaluation of upper extremity nerve impairment and summarizes inclusion criteria and causation correlation for carpal tunnel syndrome, Guyon's canal syndrome, cubital tunnel syndrome, anterior interosseous, Wartenberg's syndrome, and radial tunnel syndrome. Very mild nerve entrapments do exist and may fail to meet the AMA Guides criteria for impairment related to a diagnosis of nerve entrapment. Electrodiagnostic examination includes nerve conduction studies that assess the largest, most heavily myelinated axons, and needle electromyelography, which detects muscle membrane instability but not the sensory function of nerves. A case example from the AMA Guides, Sixth Edition, shows the process of permanent impairment rating in a case of carpal tunnel syndrome. Determination of impairment for peripheral nerve entrapments can be easily accomplished once one understands how to determine if the nerve under consideration from the electrodiagnostic evaluation demonstrates a conduction delay, a conduction block, or an axon loss. This establishes the test findings that usually are the only objective findings present.
  2. Two-Point Discrimination in the Use of Upper Extremity Nerve Function in the AMA Guides

    Richard Katz

    Pages 9–11

    DOI: 10.1001/amaguidesnewsletters.2015.JanFeb02

    Abstract
    This article presents a case report regarding a 34-year-old obese male who works as a chipper and grinder at a steel manufacturing mill and uses high-frequency vibratory power tools. He presents with typical complaints of carpal tunnel syndrome, including numbness in all five digits, wrist pain, nocturnal awakening/numbness, and others. Two-point discrimination (2PD) using a caliper was tested in the digits of the upper extremities and was 5 mm throughout. 2PD first appeared in the AMA Guides to the Evaluation of Permanent Impairment (AMA Guides), Fifth Edition, and the Sixth Edition states, “sensory deficits can be challenging to grade, since the clinical examination is based on subjective reports by the patient. Grading is based on the results of sensibility testing and two-point discrimination, to improve inter-rater reliability.” The discussion of “sensibility” involves a concept of sensory perception that is more appropriate in surgery literature than neurological literature, and the discussion of the case report in this article reflects the recent literature regarding 2PD as a measure of sensibility. The authors report that sensibility is not a simple recovery of sensory function following nerve injury but rather is a complex interaction between nerve recovery and modulation of central nervous system function in spinal cord, subcortical, and cortical structures. The authors ask if the value of 2PD in the clinical assessment of impairment has been overrated within the AMA Guides, as was range of motion in the assessment of spine impairment.
  3. Commentary on Two-Point Discrimination in the Use of Upper Extremity Nerve Function in the AMA Guides

    James B. Talmage, J. Mark Melhorn

    Pages 12–12

    DOI: 10.1001/amaguidesnewsletters.2015.JanFeb03

    Abstract
    This article responds to the previous article in this issue of The Guides Newsletter (Two-point Discrimination in the Use of Upper Extremity Nerve Function in the AMA Guides) and discusses why the AMA Guides to the Evaluation of Permanent Impairment (AMA Guides), Sixth Edition, has chosen to retain the use of static two-point discrimination for both acute single incident digital nerve injury and for upper extremity focal entrapment neuropathy. The authors clarify that the AMA Guides, Sixth Edition does not use two-point discrimination as a diagnostic criterion for entrapment neuropathy such as carpal tunnel syndrome. Instead, it uses two-point discrimination as a criterion to judge severity, specifically to help select the proper integer for the rating to be assigned for the diagnosis determined by other criteria. Two-point testing is not sensitive but is specific to significant nerve impairment (ie, severity, not diagnosis), and the authors note its advantages of being familiar to most impairment examiners, having a basis in published literature, having variations of the testing protocol that help “objectify” the apparent sensory deficit, and correlating with severity. Thus, if a rating is to be done “according to the AMA Guides,” two-point discrimination remains a required and important part of assessment of the upper extremity neurologic impairment of the hand.
  4. In Recent Literature

    Christopher R. Brigham

    Pages 13–16

    DOI: 10.1001/amaguidesnewsletters.2015.JanFeb04

    Abstract
    This column presents abstracts, as published in PudMed.gov (U.S. National Library of Medicine, National Institutes of Health) that are pertinent to the evaluation of patients who are injured or ill.
  5. Q&A: Rating C1 and C2 Fractures

    Charles N. Brooks, James B. Talmage, Marjorie Eskay-Auerbach

    Pages 15–15

    DOI: 10.1001/amaguidesnewsletters.2015.JanFeb05

AMA Newsletter

Newsletter information

ISSN
2642-0880
Publisher
American Medical Association
Publication date
1/1/2015

© 2015 American Medical Association. All Rights Reserved.

AMA Guides Digital
Cedaron Medical

Products

  • AMA Guides® Digital Subscription
  • AMA Guides® Digital + Newsletter Archive
  • ImpairmentCare
  • Compare subscriptions

AMA Guides

  • Explore AMA Guides
  • AMA Guides Training Resources
  • Contact Us
  • Subscription Terms

Account

  • Overview
  • Organizations and seats
  • Orders

© 2026 Cedaron Medical Inc. All rights reserved.

AMA Guides® is a registered trademark of the American Medical Association. © 2026 American Medical Association. All Rights Reserved.

Privacy